Nucleoside Reverse Transcriptase Inhibitor (NRTI)-Induced Neuropathy and Mitochondrial Toxicity: Limitations of the Poly-γ Hypothesis and the Potential Roles of Autophagy and Drug Transport
2024

NRTI-Induced Neuropathy and Mitochondrial Toxicity

publication Evidence: moderate

Author Information

Author(s): John Haynes, Arnav Joshi, Ross C. Larue, Eric D. Eisenmann, Rajgopal Govindarajan

Primary Institution: The Ohio State University

Hypothesis

The study investigates the mechanisms behind NRTI-induced peripheral neuropathy and mitochondrial toxicity.

Conclusion

NRTIs cause significant peripheral neuropathy and mitochondrial dysfunction, which are poorly understood and lack effective treatment options.

Supporting Evidence

  • NRTIs are crucial for HIV treatment but can cause peripheral neuropathy in 11-66% of patients.
  • Chronic exposure to NRTIs leads to mitochondrial dysfunction, affecting neuronal health.
  • Current understanding of NRTI-induced neuropathy is limited, hindering effective treatment development.

Takeaway

NRTIs, used to treat HIV, can hurt nerves and mitochondria, making it hard for patients to feel better.

Methodology

The article reviews existing literature on NRTI-induced neuropathy and mitochondrial toxicity, focusing on various proposed mechanisms.

Limitations

The study highlights that the pathogenesis of NRTI-induced neuropathy is not fully understood and cannot be explained by a single hypothesis.

Digital Object Identifier (DOI)

10.3390/pharmaceutics16121592

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication